Loading…

Searching for genetic determinants for left ventricular non-compaction

Left ventricular non-compaction (LVNC) is still a pathology around which there are numerous controversies regarding the criteria for its diagnosis, presentation, prognosis, and even classification into the appropriate group of diseases. So far, about 190 genes in which mutations may be associated wi...

Full description

Saved in:
Bibliographic Details
Published in:Quantitative imaging in medicine and surgery 2024-10, Vol.14 (10), p.7046-7060
Main Authors: Spałek, Michał, Kusińska, Aneta, Spałek, Jan, Siudak, Zbigniew, Wożakowska-Kapłon, Beata, Adamus-Białek, Wioletta
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 7060
container_issue 10
container_start_page 7046
container_title Quantitative imaging in medicine and surgery
container_volume 14
creator Spałek, Michał
Kusińska, Aneta
Spałek, Jan
Siudak, Zbigniew
Wożakowska-Kapłon, Beata
Adamus-Białek, Wioletta
description Left ventricular non-compaction (LVNC) is still a pathology around which there are numerous controversies regarding the criteria for its diagnosis, presentation, prognosis, and even classification into the appropriate group of diseases. So far, about 190 genes in which mutations may be associated with LVNC have been described, and in each of them, several to several dozen different have been discovered. We decided to analyze the frequency of single nucleotide variants (SNVs) in correlation to Petersen's criteria. We retrospectively analyzed the results of cardiac magnetic resonance (CMR) studies. Twenty-three patients who met Petersen's criteria agreed to participate in the research and take blood samples for genetic testing. Next, we prospectively included 24 volunteers who did not meet Petersen's criteria. Petersen's criteria were complied with ratio of non-compacted to compacted myocardium (NC/C) ≥2.3. A total of 47 DNA samples were analyzed based on the selected regions of the following genes: β-myosin heavy chain ( ), α-cardiac actin ( ), cardiac troponin T ( ), myosin binding protein-C ( ), LIM-domain binding protein 3 ( ), and taffazin ( ). In total, 248 substitutions in exons and introns were obtained for all analyzed samples. No statistically significant differences were detected between the mentioned groups. No significant difference in either downward or upward trends in the number of substitutions in relation to the increasing trabeculation is observed. We indicated differences in the occurrence of the studied SNVs between groups, especially for rs8037241 ( region of ) and rs2675686 ( ), but they also did not show statistical significance. Although we did not find a significant correlation between the co-occurrence of individual mutations with LVNC, it is worth noting that the presence of one of the four mutations in the range rs8037241 ( 3'UTR), rs3729998 ( . 12), and rs727503240 ( . 39) increases the risk of LVNC more than 4 times. An inverse association between the number of SNVs and the meeting the Petersen's criteria was demonstrated for studied region and rs397516254 in exon 39 of the gene. To our knowledge, no studies have been published comparing the prevalence of selected SNVs in a group of healthy subjects and in a group meeting the Petersen criteria for LVNC. Among both completely healthy individuals who did not meet the Petersen criteria for LVNC as well as those with symptoms who met these criteria we found a similar incidence of S
doi_str_mv 10.21037/qims-24-470
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11485346</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3118835977</sourcerecordid><originalsourceid>FETCH-LOGICAL-c234t-ae9bb526b89403b5bad031a99c028af3e422739f6cc42f212f93e912106f33183</originalsourceid><addsrcrecordid>eNpVkM1LAzEQxYMottTePMsePbiaZLIfOYkUq0LBg3oO2TRpI7tJm-wW_O_dfqJzmYH3eDPzQ-ia4HtKMBQPa9vElLKUFfgMDSmlkDLA-flxppwO0DjGb9xXUZKC4Es0AN4LWcmGaPqhZVBL6xaJ8SFZaKdbq5K5bnVorJOujTuh1qZNNtq1waquliFx3qXKNyupWuvdFbowso56fOgj9DV9_py8prP3l7fJ0yxVFFibSs2rKqN5VXKGocoqOcdAJOcK01Ia0IzSArjJlWLUUEINB81J_2puAEgJI_S4z111VaPnanuQrMUq2EaGH-GlFf8VZ5di4TeCEFZmwPI-4faQEPy607EVjY1K17V02ndRACFlCRkvit56t7eq4GMM2pz2ECx2-MUWv6BM9Ph7-83f207mI2z4Bc7pgdE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3118835977</pqid></control><display><type>article</type><title>Searching for genetic determinants for left ventricular non-compaction</title><source>PubMed Central</source><creator>Spałek, Michał ; Kusińska, Aneta ; Spałek, Jan ; Siudak, Zbigniew ; Wożakowska-Kapłon, Beata ; Adamus-Białek, Wioletta</creator><creatorcontrib>Spałek, Michał ; Kusińska, Aneta ; Spałek, Jan ; Siudak, Zbigniew ; Wożakowska-Kapłon, Beata ; Adamus-Białek, Wioletta</creatorcontrib><description>Left ventricular non-compaction (LVNC) is still a pathology around which there are numerous controversies regarding the criteria for its diagnosis, presentation, prognosis, and even classification into the appropriate group of diseases. So far, about 190 genes in which mutations may be associated with LVNC have been described, and in each of them, several to several dozen different have been discovered. We decided to analyze the frequency of single nucleotide variants (SNVs) in correlation to Petersen's criteria. We retrospectively analyzed the results of cardiac magnetic resonance (CMR) studies. Twenty-three patients who met Petersen's criteria agreed to participate in the research and take blood samples for genetic testing. Next, we prospectively included 24 volunteers who did not meet Petersen's criteria. Petersen's criteria were complied with ratio of non-compacted to compacted myocardium (NC/C) ≥2.3. A total of 47 DNA samples were analyzed based on the selected regions of the following genes: β-myosin heavy chain ( ), α-cardiac actin ( ), cardiac troponin T ( ), myosin binding protein-C ( ), LIM-domain binding protein 3 ( ), and taffazin ( ). In total, 248 substitutions in exons and introns were obtained for all analyzed samples. No statistically significant differences were detected between the mentioned groups. No significant difference in either downward or upward trends in the number of substitutions in relation to the increasing trabeculation is observed. We indicated differences in the occurrence of the studied SNVs between groups, especially for rs8037241 ( region of ) and rs2675686 ( ), but they also did not show statistical significance. Although we did not find a significant correlation between the co-occurrence of individual mutations with LVNC, it is worth noting that the presence of one of the four mutations in the range rs8037241 ( 3'UTR), rs3729998 ( . 12), and rs727503240 ( . 39) increases the risk of LVNC more than 4 times. An inverse association between the number of SNVs and the meeting the Petersen's criteria was demonstrated for studied region and rs397516254 in exon 39 of the gene. To our knowledge, no studies have been published comparing the prevalence of selected SNVs in a group of healthy subjects and in a group meeting the Petersen criteria for LVNC. Among both completely healthy individuals who did not meet the Petersen criteria for LVNC as well as those with symptoms who met these criteria we found a similar incidence of SNVs in the , , and genes segments analyzed. Further studies are required to confirm or exclude "potentially protective" SNV in the 39th exon of (rs397516254) and the role of co-occurrence of individual SNVs in rs8037241 ( ), rs3729998 ( ), and rs727503240 (MYH7) for the increase of the risk of LVNC.</description><identifier>ISSN: 2223-4292</identifier><identifier>EISSN: 2223-4306</identifier><identifier>DOI: 10.21037/qims-24-470</identifier><identifier>PMID: 39429584</identifier><language>eng</language><publisher>China: AME Publishing Company</publisher><subject>Original</subject><ispartof>Quantitative imaging in medicine and surgery, 2024-10, Vol.14 (10), p.7046-7060</ispartof><rights>2024 AME Publishing Company. All rights reserved.</rights><rights>2024 AME Publishing Company. All rights reserved. 2024 AME Publishing Company.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-2402-9129</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11485346/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11485346/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39429584$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Spałek, Michał</creatorcontrib><creatorcontrib>Kusińska, Aneta</creatorcontrib><creatorcontrib>Spałek, Jan</creatorcontrib><creatorcontrib>Siudak, Zbigniew</creatorcontrib><creatorcontrib>Wożakowska-Kapłon, Beata</creatorcontrib><creatorcontrib>Adamus-Białek, Wioletta</creatorcontrib><title>Searching for genetic determinants for left ventricular non-compaction</title><title>Quantitative imaging in medicine and surgery</title><addtitle>Quant Imaging Med Surg</addtitle><description>Left ventricular non-compaction (LVNC) is still a pathology around which there are numerous controversies regarding the criteria for its diagnosis, presentation, prognosis, and even classification into the appropriate group of diseases. So far, about 190 genes in which mutations may be associated with LVNC have been described, and in each of them, several to several dozen different have been discovered. We decided to analyze the frequency of single nucleotide variants (SNVs) in correlation to Petersen's criteria. We retrospectively analyzed the results of cardiac magnetic resonance (CMR) studies. Twenty-three patients who met Petersen's criteria agreed to participate in the research and take blood samples for genetic testing. Next, we prospectively included 24 volunteers who did not meet Petersen's criteria. Petersen's criteria were complied with ratio of non-compacted to compacted myocardium (NC/C) ≥2.3. A total of 47 DNA samples were analyzed based on the selected regions of the following genes: β-myosin heavy chain ( ), α-cardiac actin ( ), cardiac troponin T ( ), myosin binding protein-C ( ), LIM-domain binding protein 3 ( ), and taffazin ( ). In total, 248 substitutions in exons and introns were obtained for all analyzed samples. No statistically significant differences were detected between the mentioned groups. No significant difference in either downward or upward trends in the number of substitutions in relation to the increasing trabeculation is observed. We indicated differences in the occurrence of the studied SNVs between groups, especially for rs8037241 ( region of ) and rs2675686 ( ), but they also did not show statistical significance. Although we did not find a significant correlation between the co-occurrence of individual mutations with LVNC, it is worth noting that the presence of one of the four mutations in the range rs8037241 ( 3'UTR), rs3729998 ( . 12), and rs727503240 ( . 39) increases the risk of LVNC more than 4 times. An inverse association between the number of SNVs and the meeting the Petersen's criteria was demonstrated for studied region and rs397516254 in exon 39 of the gene. To our knowledge, no studies have been published comparing the prevalence of selected SNVs in a group of healthy subjects and in a group meeting the Petersen criteria for LVNC. Among both completely healthy individuals who did not meet the Petersen criteria for LVNC as well as those with symptoms who met these criteria we found a similar incidence of SNVs in the , , and genes segments analyzed. Further studies are required to confirm or exclude "potentially protective" SNV in the 39th exon of (rs397516254) and the role of co-occurrence of individual SNVs in rs8037241 ( ), rs3729998 ( ), and rs727503240 (MYH7) for the increase of the risk of LVNC.</description><subject>Original</subject><issn>2223-4292</issn><issn>2223-4306</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpVkM1LAzEQxYMottTePMsePbiaZLIfOYkUq0LBg3oO2TRpI7tJm-wW_O_dfqJzmYH3eDPzQ-ia4HtKMBQPa9vElLKUFfgMDSmlkDLA-flxppwO0DjGb9xXUZKC4Es0AN4LWcmGaPqhZVBL6xaJ8SFZaKdbq5K5bnVorJOujTuh1qZNNtq1waquliFx3qXKNyupWuvdFbowso56fOgj9DV9_py8prP3l7fJ0yxVFFibSs2rKqN5VXKGocoqOcdAJOcK01Ia0IzSArjJlWLUUEINB81J_2puAEgJI_S4z111VaPnanuQrMUq2EaGH-GlFf8VZ5di4TeCEFZmwPI-4faQEPy607EVjY1K17V02ndRACFlCRkvit56t7eq4GMM2pz2ECx2-MUWv6BM9Ph7-83f207mI2z4Bc7pgdE</recordid><startdate>20241001</startdate><enddate>20241001</enddate><creator>Spałek, Michał</creator><creator>Kusińska, Aneta</creator><creator>Spałek, Jan</creator><creator>Siudak, Zbigniew</creator><creator>Wożakowska-Kapłon, Beata</creator><creator>Adamus-Białek, Wioletta</creator><general>AME Publishing Company</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2402-9129</orcidid></search><sort><creationdate>20241001</creationdate><title>Searching for genetic determinants for left ventricular non-compaction</title><author>Spałek, Michał ; Kusińska, Aneta ; Spałek, Jan ; Siudak, Zbigniew ; Wożakowska-Kapłon, Beata ; Adamus-Białek, Wioletta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c234t-ae9bb526b89403b5bad031a99c028af3e422739f6cc42f212f93e912106f33183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Original</topic><toplevel>online_resources</toplevel><creatorcontrib>Spałek, Michał</creatorcontrib><creatorcontrib>Kusińska, Aneta</creatorcontrib><creatorcontrib>Spałek, Jan</creatorcontrib><creatorcontrib>Siudak, Zbigniew</creatorcontrib><creatorcontrib>Wożakowska-Kapłon, Beata</creatorcontrib><creatorcontrib>Adamus-Białek, Wioletta</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Quantitative imaging in medicine and surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Spałek, Michał</au><au>Kusińska, Aneta</au><au>Spałek, Jan</au><au>Siudak, Zbigniew</au><au>Wożakowska-Kapłon, Beata</au><au>Adamus-Białek, Wioletta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Searching for genetic determinants for left ventricular non-compaction</atitle><jtitle>Quantitative imaging in medicine and surgery</jtitle><addtitle>Quant Imaging Med Surg</addtitle><date>2024-10-01</date><risdate>2024</risdate><volume>14</volume><issue>10</issue><spage>7046</spage><epage>7060</epage><pages>7046-7060</pages><issn>2223-4292</issn><eissn>2223-4306</eissn><abstract>Left ventricular non-compaction (LVNC) is still a pathology around which there are numerous controversies regarding the criteria for its diagnosis, presentation, prognosis, and even classification into the appropriate group of diseases. So far, about 190 genes in which mutations may be associated with LVNC have been described, and in each of them, several to several dozen different have been discovered. We decided to analyze the frequency of single nucleotide variants (SNVs) in correlation to Petersen's criteria. We retrospectively analyzed the results of cardiac magnetic resonance (CMR) studies. Twenty-three patients who met Petersen's criteria agreed to participate in the research and take blood samples for genetic testing. Next, we prospectively included 24 volunteers who did not meet Petersen's criteria. Petersen's criteria were complied with ratio of non-compacted to compacted myocardium (NC/C) ≥2.3. A total of 47 DNA samples were analyzed based on the selected regions of the following genes: β-myosin heavy chain ( ), α-cardiac actin ( ), cardiac troponin T ( ), myosin binding protein-C ( ), LIM-domain binding protein 3 ( ), and taffazin ( ). In total, 248 substitutions in exons and introns were obtained for all analyzed samples. No statistically significant differences were detected between the mentioned groups. No significant difference in either downward or upward trends in the number of substitutions in relation to the increasing trabeculation is observed. We indicated differences in the occurrence of the studied SNVs between groups, especially for rs8037241 ( region of ) and rs2675686 ( ), but they also did not show statistical significance. Although we did not find a significant correlation between the co-occurrence of individual mutations with LVNC, it is worth noting that the presence of one of the four mutations in the range rs8037241 ( 3'UTR), rs3729998 ( . 12), and rs727503240 ( . 39) increases the risk of LVNC more than 4 times. An inverse association between the number of SNVs and the meeting the Petersen's criteria was demonstrated for studied region and rs397516254 in exon 39 of the gene. To our knowledge, no studies have been published comparing the prevalence of selected SNVs in a group of healthy subjects and in a group meeting the Petersen criteria for LVNC. Among both completely healthy individuals who did not meet the Petersen criteria for LVNC as well as those with symptoms who met these criteria we found a similar incidence of SNVs in the , , and genes segments analyzed. Further studies are required to confirm or exclude "potentially protective" SNV in the 39th exon of (rs397516254) and the role of co-occurrence of individual SNVs in rs8037241 ( ), rs3729998 ( ), and rs727503240 (MYH7) for the increase of the risk of LVNC.</abstract><cop>China</cop><pub>AME Publishing Company</pub><pmid>39429584</pmid><doi>10.21037/qims-24-470</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0002-2402-9129</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2223-4292
ispartof Quantitative imaging in medicine and surgery, 2024-10, Vol.14 (10), p.7046-7060
issn 2223-4292
2223-4306
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11485346
source PubMed Central
subjects Original
title Searching for genetic determinants for left ventricular non-compaction
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T17%3A45%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Searching%20for%20genetic%20determinants%20for%20left%20ventricular%20non-compaction&rft.jtitle=Quantitative%20imaging%20in%20medicine%20and%20surgery&rft.au=Spa%C5%82ek,%20Micha%C5%82&rft.date=2024-10-01&rft.volume=14&rft.issue=10&rft.spage=7046&rft.epage=7060&rft.pages=7046-7060&rft.issn=2223-4292&rft.eissn=2223-4306&rft_id=info:doi/10.21037/qims-24-470&rft_dat=%3Cproquest_pubme%3E3118835977%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c234t-ae9bb526b89403b5bad031a99c028af3e422739f6cc42f212f93e912106f33183%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3118835977&rft_id=info:pmid/39429584&rfr_iscdi=true